How Technology is Supporting the Expectation of the Cannabis Industry

Cannabis Business Insights | Friday, April 18, 2025

Fremont, CA: Cannabis has grown from the shadows to evolve into a major sector in less than two decades, achieving legal status in 16 states and Washington, D.C., and multiple overseas markets—an important turning point for the whole market. This expansion creates economic prospects and presents its own set of different obstacles. Multiple roadblocks are created by a complex regulatory framework and marketing constraints. Nevertheless, the industry's most effective driving force continues to overwhelm these developing pains: the tailored technology that allows commercial enterprise.

Compared to customary merchants, the cannabis sector is managed by a complicated web of state-by-state rules and a never-ending rotating door of municipal lawmaking. Cannabis retailers in the U.S. cannot just market. They must ensure the buyer's identity and, if necessary, medical card, calculate local taxes, follow each purchase, and report to supervisory organizations to endorse and enforce possession limitations. Yielding to the law is only half the battle—although a crucial half.

Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.

Canna-tech skills proceed to expand.

To grow their businesses and the industry effectively, retailers must do more than concede with regulatory requirements online. The sector has started to see the value of technology in practically every part of the organization, from inventory handling and point-of-sale and delivery to customer relationship management and marketing automation. Yet, the critical word is started. The lawful cannabis industry is still in its infancy, and sales and marketing techniques are novel. Luckily, canna-tech capabilities and benefits are swiftly expanding—maturing the business in the operation.

As a federally prohibited narcotic, purchasing cannabis online or with a credit card is complicated, which is why many dispensaries function on a cash-only basis. Thankfully, technology has allowed workarounds that permit customers to study and shop online yet pay in person, amounting to $9 billion in annual sales. Also, POS systems must address the cannabis industry's unique online-offline distinction. Without these technologies, dispensaries would miss a substantial amount of their online orders and have few ways to gather revenue.

Accumulating payments may seem straightforward compared to controlling inventory, which is a hard task for cannabis items. Furthermore, the technology utilized in more established, less regulated areas is incompatible with dispensary needs. For instance, while a restaurant may present 30 menu items, a dispensary may have 300 or even 3,000, necessitating comprehensive data attribution regarding strain kind, serving size, and ingredients.

For example, edibles might have up to 134 distinct characteristics. This is difficult in an industry without a standardized data collection methodology. Also, dispensaries must manage fluctuating inventory levels and ensure stock accuracy across their menu offerings. This technology did not live just a few years ago, and business owners were virtually flying blind about inventory management and allowing consumer experiences.

Prices and client needs are explored in real-time.

Customers will crowd if retailers build a dispensary. Nevertheless, cannabis businesses must extend their customer base and achieve repeat business to thrive. Because of cannabis's severe marketing restrictions, standard marketing technologies cannot fit dispensaries. Enhanced cannabis-specific marketing automation and customer relationship management (CRM) systems allow business owners to properly target marketing campaigns to customers according to their preferences. For illustration, they can send a new product notice to customers who have already bought related products. Real-time analytics on sales data allows price optimization and rapidly and precisely reveal customer insights. Realization and delivery apps can achieve a far larger audience and present greater convenience to customers when ordering and obtaining things.

The cannabis industry has gone on a long journey in the last two decades. Nevertheless, the industry is still in its infancy. The value of adaptive technology in the industry's performance will grow in importance. As more states permit adult use, the technology employed to market and identify cannabis merchants and brands must be flexible and scalable, satisfying consumers and companies wherever they are. While the chance of federal legalization is attractive, it will complicate and tax the industry's business owners and consumers.

Check Out This: Manage Marketing

More in News

A medical cannabis manufacturer can secure an attractive price for bulk flower and still face costly delays if the material arrives with inconsistent cannabinoid content or incomplete batch records. Cultivation contracts therefore carry consequences beyond agricultural supply. A shipment rejected during incoming quality review can disrupt extraction schedules, while replacement material may require fresh testing before manufacturing resumes. Product specifications should establish what the grower can reproduce across harvests, rather than describing an especially successful crop. Cannabinoid profiles and microbial limits affect whether flower can enter a downstream process without rework. Moisture content introduces additional requirements. Buyers benefit from examining historical batch results alongside the supplier's methods for controlling growing conditions. A certificate of analysis documents an individual lot; production history provides a better view of consistency across seasons. Greenhouse and indoor cultivation bring different cost structures. Natural sunlight can reduce energy requirements, but environmental exposure introduces variables that cultivation teams must manage. Indoor facilities offer more direct control over lighting and climate at a higher infrastructure cost. Neither approach eliminates variability. The relevant comparison concerns the controls actually applied and the landed cost of material consistently meeting the contracted specification. Production capacity figures can be misleading when quoted apart from usable output. Installed growing area does not indicate how much compliant flower is available at a given time, particularly when crops move through harvesting, drying and quality release. Procurement teams should establish expected lead times and realistic supply commitments, including procedures for handling lots that fail acceptance limits. Contracts built around nominal annual capacity leave little protection against interrupted deliveries. " Clever Leaves’ development work includes cannabinoid profiles and private-label formulations, while experience shipping to international markets informs the documentation required for regulated distribution. " Traceability becomes harder when cultivation and extraction sit with separate businesses. Batch identities must survive transfers between facilities, and processing records must connect finished ingredients to the plants from which they originated. Poorly reconciled records can complicate investigations or create delays in releasing material for pharmaceutical use. Seed-to-sale systems are useful only when they capture meaningful events and support retrieval of records for a specific shipment. Different markets also impose different demands on production documentation. A supplier's certification may cover extraction but not cultivation, or apply to one facility rather than every product offered. Executives should verify the certified activities and the documentation available for the destination market. Import permissions and distribution arrangements remain separate from production qualifications. A manufacturer planning several international launches may require different product formats and specification packages, supported by knowledge of local regulatory requirements rather than a single undifferentiated supply agreement. Clever Leaves International Inc. (OTC: CLVR) combines greenhouse cultivation in Colombia with extraction and processing for medical cannabis customers. Its portfolio extends from flower to standardized cannabinoid extracts and finished oral formulations, allowing manufacturers to source material at different points in production. The company reports European Union GMP certification for extraction, Colombian GMP certification and Good Agricultural and Collection Practices certification. Clever Leaves also uses seed-to-sale tracking to document material movement through production. Its development work includes cannabinoid profiles and privatelabel formulations, while experience shipping to international markets informs the documentation required for regulated distribution. Pharmaceutical manufacturers sourcing both bulk material and more developed cannabinoid products across jurisdictions have a defined use for this integrated approach. ...Read more